Home Newsfeeds Keybanc Maintains Overweight on Inspire Medical Systems, Raises Price Target to $303

Keybanc Maintains Overweight on Inspire Medical Systems, Raises Price Target to $303

Keybanc analyst Matthew Mishan maintains Inspire Medical Systems (NYSE:INSP) with a Overweight and raises the price target from $287 to $303.

byBenzinga Newsdesk

January 13, 2023

1 minute read

Keybanc analyst Matthew Mishan maintains Inspire Medical Systems (NYSE:INSP) with a Overweight and raises the price target from $287 to $303.

General
News

Toyota Registers 23% Growth In October Global Vehicle Production

By Shivani Kumaresan

November 29, 7:01 AM

Toyota Motor Corp (NYSE:TM) reported a 23% increase in global vehicle production to 771,382 units in the month of October. The…

Dell Technologies CFO Says Back Half Of Next Year Has Fair Amount Of Complexity, Co. Expects Current Factors To Have Financial Outcomes In H2 Next Year

By Michael Horton

November 21, 5:58 PM

-Reuters Citing Conference Call

DELL

Fresh EU Tariffs Could Slow Down Tesla Chinese Rivals, But Warren Buffett-Backed BYD ‘Can Profitably Export Even At A 35% Tariff,’ Says Expert

By Benzinga Neuro

June 13, 5:31 AM

The European Union has introduced new tariffs on electric vehicles manufactured in China, a move that could pose challenges for Chinese automakers. However, companies like BYD are expected to remain competitive.

BYDDF

Wells Fargo Maintains Overweight on Dun & Bradstreet Hldgs, Lowers Price Target to $17

By Benzinga Newsdesk

February 17, 11:11 AM

Wells Fargo analyst Seth Weber maintains Dun & Bradstreet Hldgs (NYSE:DNB) with a Overweight and lowers the price target from $20 to $17.

DNB

Keybanc Maintains Overweight on Inspire Medical Systems, Raises Price Target to $303

Related Posts

Toyota Registers 23% Growth In October Global Vehicle Production

Dell Technologies CFO Says Back Half Of Next Year Has Fair Amount Of Complexity, Co. Expects Current Factors To Have Financial Outcomes In H2 Next Year

Fresh EU Tariffs Could Slow Down Tesla Chinese Rivals, But Warren Buffett-Backed BYD ‘Can Profitably Export Even At A 35% Tariff,’ Says Expert

Wells Fargo Maintains Overweight on Dun & Bradstreet Hldgs, Lowers Price Target to $17